These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1076 related articles for article (PubMed ID: 8441253)

  • 1. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
    Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pallid mice with genetic emphysema. Neutrophil elastase burden and elastin loss occur without alteration in the bronchoalveolar lavage cell population.
    de Santi MM; Martorana PA; Cavarra E; Lungarella G
    Lab Invest; 1995 Jul; 73(1):40-7. PubMed ID: 7603039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
    Cavarra E; Martorana PA; Gambelli F; de Santi M; van Even P; Lungarella G
    Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scanning electron microscopic investigation of genetic emphysema in tight-skin, pallid, and beige mice, three different C57 BL/6J mutants.
    Keil M; Lungarella G; Cavarra E; van Even P; Martorana PA
    Lab Invest; 1996 Feb; 74(2):353-62. PubMed ID: 8780155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deficiency in alpha 1 proteinase inhibitor (alpha 1 PI) associated with emphysema.
    Martorana PA; Lungarella G
    Lab Anim Sci; 1998 Oct; 48(5):460-2. PubMed ID: 10090058
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of excised lung gas volume measurements in animals with genetic or induced emphysema.
    Jansson AH; Smailagic A; Andersson AM; Zackrisson C; Fehniger TE; Stevens TR; Wang X
    Respir Physiol Neurobiol; 2006 Feb; 150(2-3):240-50. PubMed ID: 15908285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of antielastase activity in the development of pulmonary emphysema in a family with alpha 1-antitrypsin deficiency].
    Kishi F; Kakinoki A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):565-70. PubMed ID: 2615095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
    Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
    N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
    Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
    J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental studies on emphysema and chronic bronchial injury.
    Snider GL
    Eur J Respir Dis Suppl; 1986; 146():17-35. PubMed ID: 3536550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protease inhibitory capacity. (Recent knowledge on alpha 1-antitrypsin deficiency).
    Massi G; Bruscalupi G; Auconi P
    Ric Clin Lab; 1982; 12(3):449-58. PubMed ID: 6291123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.
    Blank CA; Brantly M
    Ann Allergy; 1994 Feb; 72(2):105-20; quiz 120-2. PubMed ID: 8109800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
    Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
    J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy for alpha 1-antitrypsin deficiency. Hopes, realities and perspectives].
    LeMarchand P
    Rev Mal Respir; 1996; 13(1):7-12. PubMed ID: 8650421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current views on the pathogenesis and treatment of pulmonary emphysema and chronic bronchitis].
    Fal A
    Wiad Lek; 1992 Mar; 45(5-6):233-9. PubMed ID: 1455869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1-antitrypsin deficiency.
    Idell S; Cohen AB
    Clin Chest Med; 1983 Sep; 4(3):359-75. PubMed ID: 6357600
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
    Ogushi F; Hubbard RC; Vogelmeier C; Fells GA; Crystal RG
    J Clin Invest; 1991 Mar; 87(3):1060-5. PubMed ID: 1999486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation therapy of alpha 1-antitrypsin deficiency.
    Hubbard RC; Crystal RG
    Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two decades of research in the pathogenesis of emphysema.
    Snider GL
    Schweiz Med Wochenschr; 1984 Jun; 114(25):898-906. PubMed ID: 6379868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.